US Stock MarketDetailed Quotes
TCBP TC BioPharm
- 6.5882
- +0.4382+7.13%
Trading Sep 13 10:44 ET
3.26MMarket Cap-33P/E (TTM)
6.8500High6.4600Low114.22KVolume6.5000Open6.1500Pre Close751.00KTurnover23.23%Turnover RatioLossP/E (Static)494.51KShares138.000052wk High2.29P/B3.24MFloat Cap2.110152wk Low--Dividend TTM491.73KShs Float35000.0000Historical High--Div YieldTTM6.34%Amplitude2.1100Historical Low6.5740Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
TC BioPharm Stock Forum
TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial
TC BioPharm (NASDAQ: TCBP) has announced significant progress in its ACHIEVE Phase 2b clinical trial for TCB008, an allogeneic gamma-delta T cell therapy for cancer. The trial, focusing on patients with AML or MDS/AML, has reached a important milestone with the first patient completing the full dose regimen of approximately one billion cells. Importantly, no TCB008-related adverse ev...
TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox
TC BioPharm (NASDAQ: TCBP) has announced plans to initiate Proof of Concept preclinical studies for its lead therapeutic TCB 008 in the treatment of monkeypox. TCB008 is an allogeneic unmodified cell therapy composed of activated and expanded gamma delta T (GDT) cells. The company aims to partner with a leading Infectious Disease Center or University to rapidly advance these studies.
CEO Brya...
TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering
TC BioPharm (NASDAQ: TCBP) has successfully closed its upsized $6.0 million public offering. The offering included 6,000,000 American Depository Shares (ADSs) or pre-funded warrants, along with Series H warrants to purchase up to 6,000,000 ADSs at a combined price of $1 per ADS. The Series H Warrants have an exercise price of £0.76 per ADS and will expire in one year. Each ADS represents 200 ordinary...
No comment yet